Dr. Reddy's Expands European Operations
Dr. Reddy’s has expanded its commercial operations in Europe with the introduction of its range of generic drugs in France.
Dr. Reddy’s Laboratories has expanded its commercial operations in Europe with the introduction of its range of generic drugs in France. The first products, which include cancer drugs, anti-infectives, and antimycotics, will be made available in the hospital market in March 2017.
The company also recently launched select products of its hospital portfolio in Italy and Spain, and is looking to expand its business in these regions with the launch of anti-HIV products this year.
Dr. Reddy’s has a portfolio of injectables and complex generic drugs. The company currently has two R&D centres, one manufacturing, and a packaging and storage facility in Europe.
Source: Dr. Reddy’s
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
PostEra Expands Pfizer Partnership with AI Lab and ADC Collaborations
January 8th 2025The AI Lab was launched almost exactly three years ago and has produced several programs so far, at least one of which achieved its first scientific stage gate 40% faster than the teams originally forecasted.
